- Apolipoproteins as Differentiating and Predictive Markers for Assessing Clinical Outcomes in Patients with Small Cell Lung Cancer
-
Shi J, Yang H, Duan X, Li L, Sun L, Li Q, Zhang J
- KMID: 2374071
- Yonsei Med J.
- 2016 May;57(3):549-556.
- doi: 10.3349/ymj.2016.57.3.549
PURPOSE: The present study aimed to investigate the value of apolipoproteins, including ApoA-1, ApoC-III, and ApoE, in patients with small cell lung cancer (SCLC) as potential biomarkers for diagnosis, prognosis,... -
- CITED
-
- Close
- SHARE
-
- Close
- A point mutant of apolipoprotein A-I, V156K, exhibited potent anti-oxidant and anti-atherosclerotic activity in hypercholesterolemic C57BL/6 mice
-
Cho KH, Park SH, Han JM, Kim HC, Chung YJ, Choi I, Kim JR
- KMID: 1094656
- Exp Mol Med.
- 2007 Apr;39(2):160-169.
In our previous study, two point mutants of apolipoprotein A-I, designated V156K and A158E, revealed peculiar characteristics in their lipid-free and lipid-bound states. In order to determine the putative therapeutic... -
- CITED
-
- Close
- SHARE
-
- Close
